Cancer treatment is undergoing a significant transformation as targeted biologic therapies gain greater importance in oncology care. Rising cancer incidence, an aging global population, and increasing demand for more precise treatment approaches are strengthening the adoption of advanced antibody-based therapies. The Cancer Monoclonal Antibodies Market was valued at US$ 167,627.55 million in...